• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)患者行肺减容术(LVRS)前后,EQ-5D-3L 与 SF-6D 生活质量(QOL)问卷的比较。

Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS).

机构信息

Center for Clinical Research, Southern Illinois University School of Medicine, Springfield, USA.

Department of Surgery, Southern Illinois University School of Medicine, Springfield, USA.

出版信息

Qual Life Res. 2019 Jul;28(7):1885-1892. doi: 10.1007/s11136-019-02123-x. Epub 2019 Feb 1.

DOI:10.1007/s11136-019-02123-x
PMID:30707368
Abstract

PURPOSE

Lung volume reduction surgery (LVRS) has been shown to improve lung function, but also improve the overall quality of life (QOL). The aim of this study is to compare two QOL questionnaires-EuroQol Questionnaire (EQ-5D-3L) and 36-item Short Form Health Survey (SF-36) in patients post-LVRS.

METHODS

All patients undergoing LVRS for severe chronic obstructive pulmonary disease (COPD) at a single center of excellence were analyzed (n = 94). Baseline demographic and clinical outcomes were characterized. Both EQ-5D-3L and SF-36 questionnaires were administered to all patients at baseline (n = 94) and at the end of 1 year (n = 89) post-surgery. SF-36 was converted to Short Form six-dimensions (SF-6D) using standard algorithm. Correlation, discrimination, responsiveness and differences across the two questionnaires were examined.

RESULTS

The mean age of patients enrolled in the cohort was 66 years. There was significant increase in forced expiratory volume (FEV1, 43%), forced vital capacity (FVC 46%), diffusion capacity (DLCO 15%), 6 min walk distance test (6MWD 21%) and a significant decrease in residual volume (RV 23%) at the end of 1-year follow-up. The overall mean utility index significantly improved for both SF-6D and EQ-5D-3L questionnaires at the end of follow-up (p = 0.0001). However, the magnitude of percentage increase was higher with EQ-5D-3L compared to SF-6D (32% vs. 13%). Stronger correlations confirmed convergent validity at the end of 1-year follow-up between similar domains. Both questionnaires failed to discriminate between different levels of disease severity post-LVRS in patients with severe COPD.

CONCLUSIONS

Both questionnaires responded similarly in patients with COPD post-LVRS. Combining results from QOL questionnaire(s) along with symptoms of disease and history of exacerbation may be a possible solution for identifying disease severity in old and sick patients unwilling/unable to come to hospital for a pulmonary function test post-LVRS.

摘要

目的

肺减容术(LVRS)已被证明能改善肺功能,但也能提高整体生活质量(QOL)。本研究旨在比较两种 QOL 问卷——欧洲五维健康量表(EQ-5D-3L)和 36 项简短健康调查问卷(SF-36)在 LVRS 术后患者中的应用。

方法

在一个卓越中心对所有接受 LVRS 治疗严重慢性阻塞性肺疾病(COPD)的患者进行分析(n=94)。对基线人口统计学和临床结局进行特征描述。在基线(n=94)和术后 1 年(n=89)时,所有患者均接受 EQ-5D-3L 和 SF-36 问卷。SF-36 使用标准算法转换为六维度简短健康调查问卷(SF-6D)。检验了两个问卷之间的相关性、区分度、反应度和差异。

结果

入组患者的平均年龄为 66 岁。术后 1 年随访时,用力呼气量(FEV1,43%)、用力肺活量(FVC,46%)、弥散量(DLCO,15%)和 6 分钟步行距离(6MWD,21%)显著增加,残气量(RV,23%)显著减少。随访结束时,SF-6D 和 EQ-5D-3L 问卷的总体平均效用指数均显著提高(p=0.0001)。然而,EQ-5D-3L 的百分比增加幅度高于 SF-6D(32% vs. 13%)。在 1 年随访结束时,相似领域之间的相关性较强,证实了两种问卷的收敛效度。在 LVRS 术后严重 COPD 患者中,两种问卷均不能区分疾病严重程度。

结论

在 LVRS 术后的 COPD 患者中,两种问卷的反应相似。将 QOL 问卷(s)的结果与疾病症状和加重病史相结合,可能是识别 LVRS 术后不愿/不能到医院进行肺功能检查的老年和体弱患者疾病严重程度的一种方法。

相似文献

1
Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS).慢性阻塞性肺疾病(COPD)患者行肺减容术(LVRS)前后,EQ-5D-3L 与 SF-6D 生活质量(QOL)问卷的比较。
Qual Life Res. 2019 Jul;28(7):1885-1892. doi: 10.1007/s11136-019-02123-x. Epub 2019 Feb 1.
2
Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?采用通用的欧洲五维健康量表问卷测量的慢性阻塞性肺疾病(COPD)患者的生活质量能否区分COPD的严重程度阶段?
Chest. 2006 Oct;130(4):1117-28. doi: 10.1378/chest.130.4.1117.
3
EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.症状性良性甲状腺结节的 EQ-5D-5L 和 SF-6D 效用测量:可接受性和心理测量评估。
Patient. 2017 Aug;10(4):447-454. doi: 10.1007/s40271-017-0220-5.
4
Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis.CFQ-R-8D 与 EQ-5D-3L 和 SF-6D 在囊性纤维化患者中的心理测量性能比较。
J Patient Rep Outcomes. 2024 Feb 28;8(1):24. doi: 10.1186/s41687-024-00697-w.
5
Comparison of health-related quality of life and functional recovery measurement tools in out-of-hospital cardiac arrest survivors.院外心脏骤停幸存者健康相关生活质量与功能恢复测量工具的比较
Resuscitation. 2016 Oct;107:57-64. doi: 10.1016/j.resuscitation.2016.07.242. Epub 2016 Aug 10.
6
Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease.心血管疾病患者中EQ-5D-3L与SF-6D(SF-12)同期效用评分的比较。
Qual Life Res. 2017 Dec;26(12):3399-3408. doi: 10.1007/s11136-017-1666-6. Epub 2017 Aug 1.
7
Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.基于偏好的测量指标的日本人群规范:EQ-5D-3L、EQ-5D-5L和SF-6D。
Qual Life Res. 2016 Mar;25(3):707-19. doi: 10.1007/s11136-015-1108-2. Epub 2015 Aug 25.
8
Stability of improvements in exercise performance and quality of life following bilateral lung volume reduction surgery in severe COPD.重度慢性阻塞性肺疾病患者双侧肺减容术后运动能力和生活质量改善的稳定性
Chest. 1997 Oct;112(4):907-15. doi: 10.1378/chest.112.4.907.
9
Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.《腰痛患者欧洲五维健康量表 5 维度 5 水平版与六维度简短量表效用测量的差异心理测量学特性》
Spine (Phila Pa 1976). 2019 Jun 1;44(11):E679-E686. doi: 10.1097/BRS.0000000000002939.
10
Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.在哮喘中,特定疾病效用值是否比基于通用偏好的效用值更有效?一项比较EQ-5D-3L、SF-6D与AQL-5D的研究证据。
Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):667-675. doi: 10.1080/14737167.2018.1505506. Epub 2018 Aug 3.

引用本文的文献

1
Comparison of the measurement properties and consistency between the EQ-5D-3L and EQ-5D-Y-3L in adolescents aged 15-17 in China.中国 15-17 岁青少年中 EQ-5D-3L 与 EQ-5D-Y-3L 的测量特性和一致性比较。
Health Qual Life Outcomes. 2024 Jul 29;22(1):59. doi: 10.1186/s12955-024-02275-6.
2
Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China.比较 EQ-5D-5L 和 SF-6Dv2 在超重和肥胖人群中的测量特性。
Health Qual Life Outcomes. 2023 Oct 31;21(1):118. doi: 10.1186/s12955-023-02202-1.
3
Perspectives on Aging and Quality of Life.

本文引用的文献

1
The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies.转移性去势抵抗性前列腺癌患者健康相关生活质量评分与临床结局之间的关联:AFFIRM和PREVAIL研究的探索性分析。
Eur J Cancer. 2017 Dec;87:21-29. doi: 10.1016/j.ejca.2017.09.035. Epub 2017 Oct 31.
2
Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease.心血管疾病患者中EQ-5D-3L与SF-6D(SF-12)同期效用评分的比较。
Qual Life Res. 2017 Dec;26(12):3399-3408. doi: 10.1007/s11136-017-1666-6. Epub 2017 Aug 1.
3
衰老与生活质量的观点
Healthcare (Basel). 2023 Jul 26;11(15):2131. doi: 10.3390/healthcare11152131.
4
Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population.中国一般人群中 EQ-5D-5L 与 SF-6Dv2 之间的比较性能和映射算法。
Eur J Health Econ. 2024 Feb;25(1):7-19. doi: 10.1007/s10198-023-01566-x. Epub 2023 Jan 29.
5
Clinical Observation of General Anesthesia Combined with Spinal Anesthesia in Elderly Patients with Chronic Obstructive Pulmonary Disease.老年慢性阻塞性肺疾病患者全身麻醉复合椎管内麻醉的临床观察。
Biomed Res Int. 2022 Aug 21;2022:9160145. doi: 10.1155/2022/9160145. eCollection 2022.
6
Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.SF-6Dv2 和 EQ-5D-5L 在中国人群健康调查中的测量性能比较。
Health Qual Life Outcomes. 2022 Jun 16;20(1):96. doi: 10.1186/s12955-022-02003-y.
7
Narrow-band UVB combined with compound clobetasol propionate can improve the therapeutic effect in hand eczema patients.窄谱中波紫外线联合复方丙酸氯倍他索可提高手部湿疹患者的治疗效果。
Am J Transl Res. 2021 Jul 15;13(7):8193-8199. eCollection 2021.
8
Translation, Pilot Psychometric Validation, and Comparative Performance of the Arabic Version of the Anti-Clot Treatment Scale (ACTS).抗凝血治疗量表(ACTS)阿拉伯语版本的翻译、初步心理测量学验证及比较性能
J Pharm Bioallied Sci. 2021 Jan-Mar;13(1):61-68. doi: 10.4103/jpbs.JPBS_395_20. Epub 2020 Dec 16.
9
Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.血液恶性肿瘤患儿的 EQ-5D-Y-3L 和 EQ-5D-Y-5L 的患者-照顾者一致性和重测信度。
Eur J Health Econ. 2021 Sep;22(7):1103-1113. doi: 10.1007/s10198-021-01309-w. Epub 2021 May 5.
10
The anti-clot treatment scale (ACTS): validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia.抗栓治疗量表(ACTS):在沙特阿拉伯接受华法林治疗的患者中对翻译后的阿拉伯语版本进行验证。
Health Qual Life Outcomes. 2020 Jul 6;18(1):215. doi: 10.1186/s12955-020-01471-4.
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.
在一项晚期胰腺癌国际III期试验(NCIC CTG PA.3)中,生活质量评分的基线及变化在预测临床结局方面的意义
Pancreatology. 2016 Nov-Dec;16(6):1106-1112. doi: 10.1016/j.pan.2016.08.013. Epub 2016 Aug 30.
4
Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.评估慢性阻塞性肺疾病患者与健康相关的生活质量:比较通用型和疾病特异性工具,并重点关注合并症。
BMC Pulm Med. 2016 May 10;16(1):70. doi: 10.1186/s12890-016-0238-9.
5
Health State Utility Value in Chronic Obstructive Pulmonary Disease (COPD); The Challenge of Heterogeneity: A Systematic Review and Meta-Analysis.慢性阻塞性肺疾病(COPD)中的健康状态效用值;异质性挑战:一项系统评价与Meta分析
COPD. 2016 Jun;13(3):380-98. doi: 10.3109/15412555.2015.1092953. Epub 2015 Dec 17.
6
Can The EQ-5D Detect Meaningful Change? A Systematic Review.EQ-5D能否检测出有意义的变化?一项系统评价。
Pharmacoeconomics. 2015 Nov;33(11):1137-54. doi: 10.1007/s40273-015-0295-6.
7
Employment and activity limitations among adults with chronic obstructive pulmonary disease--United States, 2013.2013年美国慢性阻塞性肺疾病成年患者的就业及活动受限情况
MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):289-95.
8
A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病(COPD)患者中EQ-5D与SF-6D的比较。
PLoS One. 2014 Nov 7;9(11):e112389. doi: 10.1371/journal.pone.0112389. eCollection 2014.
9
Quality of well-being outcomes in the National Emphysema Treatment Trial.国家肺气肿治疗试验中的幸福结局质量。
Chest. 2015 Feb;147(2):377-387. doi: 10.1378/chest.14-0528.
10
Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.多发性骨髓瘤癌症的通用型、疾病特异性和映射健康状态效用值比较。
Value Health. 2012 Dec;15(8):1059-68. doi: 10.1016/j.jval.2012.08.2201.